
Supply chain priorities of U.S. provider and pharma/life sciences executives 2021
According to a survey conducted among health service provider and pharmaceutical/life science executives in August-September 2020, 50 percent of pharmaceutical/life sciences executives said their pripority will be to improve supply chain transparency in 2021. This statistic illustrates the supply chain priorities in 2021 reported by U.S. health services provider and pharma/life sciences executives.